BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38759418)

  • 1. Sodium-glucose cotransporter 2 inhibitors attenuate vascular calcification by suppressing endoplasmic reticulum protein thioredoxin domain containing 5 dependent osteogenic reprogramming.
    Wu S; Luo X; Chen Y; Wang Z; Liu X; Sun N; Zhao J; Luo W; Zhang J; Tong X; Huang L; Liu C; Qin Z
    Redox Biol; 2024 Jul; 73():103183. PubMed ID: 38759418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of c1q/tumor necrosis factor-related protein-3 promotes phosphate-induced vascular smooth muscle cell calcification both in vivo and in vitro.
    Zhou Y; Wang JY; Feng H; Wang C; Li L; Wu D; Lei H; Li H; Wu LL
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1002-10. PubMed ID: 24578384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TDAG51 (T-Cell Death-Associated Gene 51) Is a Key Modulator of Vascular Calcification and Osteogenic Transdifferentiation of Arterial Smooth Muscle Cells.
    Platko K; Lebeau PF; Gyulay G; Lhoták Š; MacDonald ME; Pacher G; Hyun Byun J; Boivin FJ; Igdoura SA; Cutz JC; Bridgewater D; Ingram AJ; Krepinsky JC; Austin RC
    Arterioscler Thromb Vasc Biol; 2020 Jul; 40(7):1664-1679. PubMed ID: 32434409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoplasmic Reticulum Stress-Mediated Apoptosis Contributing to High Glucose-Induced Vascular Smooth Muscle Cell Calcification.
    Zhu Q; Guo R; Liu C; Fu D; Liu F; Hu J; Jiang H
    J Vasc Res; 2015; 52(5):291-8. PubMed ID: 26890314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoplasmic Reticulum Stress Mediates Vascular Smooth Muscle Cell Calcification via Increased Release of Grp78 (Glucose-Regulated Protein, 78 kDa)-Loaded Extracellular Vesicles.
    Furmanik M; van Gorp R; Whitehead M; Ahmad S; Bordoloi J; Kapustin A; Schurgers LJ; Shanahan CM
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):898-914. PubMed ID: 33297752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermedin
    Ren JL; Hou YL; Ni XQ; Zhu Q; Chen Y; Zhang LS; Liu X; Xue CD; Wu N; Yu YR; Tang CS; Ning ZP; Chai SB; Qi YF
    J Cardiovasc Pharmacol Ther; 2020 May; 25(3):251-264. PubMed ID: 31698947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice.
    Lee DM; Battson ML; Jarrell DK; Hou S; Ecton KE; Weir TL; Gentile CL
    Cardiovasc Diabetol; 2018 Apr; 17(1):62. PubMed ID: 29703207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes.
    Birnbaum Y; Bajaj M; Yang HC; Ye Y
    Cardiovasc Drugs Ther; 2018 Apr; 32(2):135-145. PubMed ID: 29508169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indoleamine 2,3-Dioxygenase 1 Deletion-Mediated Kynurenine Insufficiency in Vascular Smooth Muscle Cells Exacerbates Arterial Calcification.
    Ouyang L; Yu C; Xie Z; Su X; Xu Z; Song P; Li J; Huang H; Ding Y; Zou MH
    Circulation; 2022 Jun; 145(24):1784-1798. PubMed ID: 35582948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium-glucose cotransporter 2 inhibitor canagliflozin alleviates vascular calcification through suppression of nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 inflammasome.
    Chen A; Lan Z; Li L; Xie L; Liu X; Yang X; Wang S; Liang Q; Dong Q; Feng L; Li Y; Ye Y; Fu M; Lu L; Yan J
    Cardiovasc Res; 2023 Oct; 119(13):2368-2381. PubMed ID: 37523743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin comparison with insulin shows important effects on Zn
    Olgar Y; Turan B
    Can J Physiol Pharmacol; 2019 Jun; 97(6):528-535. PubMed ID: 30444646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonylation of Runx2 at K176 by 4-Hydroxynonenal Accelerates Vascular Calcification.
    Zhai X; Cao S; Wang J; Qiao B; Liu X; Hua R; Zhao M; Sun S; Han Y; Wu S; Pang J; Yuan Q; Wang B; Xu F; Wei S; Chen Y
    Circulation; 2024 May; 149(22):1752-1769. PubMed ID: 38348663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WNT/β-catenin signaling promotes VSMCs to osteogenic transdifferentiation and calcification through directly modulating Runx2 gene expression.
    Cai T; Sun D; Duan Y; Wen P; Dai C; Yang J; He W
    Exp Cell Res; 2016 Jul; 345(2):206-17. PubMed ID: 27321958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High phosphorus level leads to aortic calcification via β-catenin in chronic kidney disease.
    Yao L; Sun YT; Sun W; Xu TH; Ren C; Fan X; Sun L; Liu LL; Feng JM; Ma JF; Wang LN
    Am J Nephrol; 2015; 41(1):28-36. PubMed ID: 25634106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress by Ca
    Nguyen NT; Nguyen TT; Da Ly D; Xia JB; Qi XF; Lee IK; Cha SK; Park KS
    Am J Physiol Heart Circ Physiol; 2020 Dec; 319(6):H1302-H1312. PubMed ID: 33095057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimethylamine-N-Oxide Promotes Vascular Calcification Through Activation of NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome and NF-κB (Nuclear Factor κB) Signals.
    Zhang X; Li Y; Yang P; Liu X; Lu L; Chen Y; Zhong X; Li Z; Liu H; Ou C; Yan J; Chen M
    Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):751-765. PubMed ID: 31941382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dapagliflozin Suppresses ER Stress and Improves Subclinical Myocardial Function in Diabetes: From Bedside to Bench.
    Shih JY; Lin YW; Fisch S; Cheng JT; Kang NW; Hong CS; Chen ZC; Chang WT
    Diabetes; 2021 Jan; 70(1):262-267. PubMed ID: 33115828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptidyl peptidase-4 inhibitor gemigliptin protects against vascular calcification in an experimental chronic kidney disease and vascular smooth muscle cells.
    Choi SY; Ryu HM; Oh EJ; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
    PLoS One; 2017; 12(7):e0180393. PubMed ID: 28686724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unspliced XBP1 Counteracts β-Catenin to Inhibit Vascular Calcification.
    Yang L; Dai R; Wu H; Cai Z; Xie N; Zhang X; Shen Y; Gong Z; Jia Y; Yu F; Zhao Y; Lin P; Ye C; Hu Y; Fu Y; Xu Q; Li Z; Kong W
    Circ Res; 2022 Jan; 130(2):213-229. PubMed ID: 34870453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reticulocalbin 2 enhances osteogenic differentiation of human vascular smooth muscle cells in diabetic conditions.
    Chang Z; Yan G; Yan H; Zheng J; Liu Z
    Life Sci; 2019 Sep; 233():116746. PubMed ID: 31401313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.